Anesthetic Challenges in Hirayama Disease Patients Undergoing Cervical Spine Surgery—A Case Series

Abstract

Hirayama disease (HD) is a rare disease, resulting from cervical compressive myelopathy, manifesting as upper limb muscular atrophy, and rarely autonomic and upper motor neuron signs. Anesthesia management is challenging—careful neck positioning during bag-mask ventilation and endotracheal intubation, avoidance of drugs that release histamine, multimodal monitoring to avoid delayed recovery, anticipation of hypotension, and blood loss due to autonomic dysfunction—all this is necessary for successful outcome of general anesthesia in HD patients. This case series demonstrates that preexisting autonomic dysfunction in HD patients should alert the anesthesiologists regarding higher likelihood of hemodynamic perturbations and blood loss, compared with patients who have normal autonomic functions, and henceforth take appropriate precautionary measures.

Keywords

Hirayama disease - motor neuron disease - spinal - muscular atrophy - nonprogressive

Publikationsverlauf

Artikel online veröffentlicht:
08. August 2024

• References

• 1 Monteiro JN, Bedekar UP, Sankhe M, Nandkumar S. Anesthetic considerations in Hirayama disease: primum non nocere. J Anaesthesiol Clin Pharmacol 2023; 39 (01) 160-161
• 2 Tashiro K, Kikuchi S, Itoyama Y. et al. Nationwide survey of juvenile muscular atrophy of distal upper extremity (Hirayama disease) in Japan. Amyotroph Lateral Scler 2006; 7 (01) 38-45
• 3 Yoo SD, Kim HS, Yun DH. et al. Monomelic amyotrophy (Hirayama disease) with upper motor neuron signs: a case report. Ann Rehabil Med 2015; 39 (01) 122-127
• 4 Kikuchi S, Tashiro K, Kitagawa M, Iwasaki Y, Abe H. [A mechanism of juvenile muscular atrophy localized in the hand and forearm (Hirayama disease)–flexion myelopathy with tight dural canal in flexion]. Rinsho Shinkeigaku 1987; 27 (04) 412-419
• 5 Anuradha S, Fanai V. Hirayama disease: a rare disease with unusual features. Case Rep Neurol Med 2016; 2016: 5839761
• 6 Hirayama K. Juvenile muscular atrophy of distal upper extremity (Hirayama disease): focal cervical ischemic poliomyelopathy. Neuropathology 2000; 20 (Suppl): S91-S94
• 7 Wang H, Tian Y, Wu J. et al. Update on the pathogenesis, clinical diagnosis, and treatment of Hirayama disease. Front Neurol 2022; 12: 811943
• 8 Das A, Pradhan S. Cardiovascular and sudomotor dysfunction in Hirayama disease. Acta Neurol Belg 2021; 121 (02) 545-553
• 9 Reddy A, Varma P, Barik AK, Narayan V. Anesthetic challenges in a patient with Hirayama disease with quadriparesis and autonomic dysfunction undergoing cervical spine surgery. J Neurosci Rural Pract 2024; 15 (01) 137-139
• 10 Ito S, Kuwabara S, Fukutake T, Tokumaru Y, Hattori T. HyperIgEaemia in patients with juvenile muscular atrophy of the distal upper extremity (Hirayama disease). J Neurol Neurosurg Psychiatry 2005; 76 (01) 132-134